Interferon-α (Flamel Technologies)

N/A

Report date: 2022/03/04 16:46:36

Base Information

Drug NameInterferon-α (Flamel Technologies)
Drug Alias NameIFN alfa-2b XLIFN-α XLIFN alpha-2b XLLong-acting IFN-α XLInterferon alfa-2b XL +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvadel Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvadel Pharmaceuticals Plc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeL03AB05
Related LinksN/A